Does A New Pharmacoeconomic Model Is Demanded for Obesity’s Pharmacotherapy Assessment?
2015 ◽
Vol 18
(7)
◽
pp. A681
BS Riveros
◽
RC Luchetta
◽
R Radominski
◽
CJ Correr
◽
O Wu
2001 ◽
Vol 4
(2)
◽
pp. 105
WJ Spruill
◽
WE Wade
◽
RB Leslie
2015 ◽
Vol 3
(3)
◽
pp. 42-45
◽
R.I. Yagudina
◽
D.G. Tishchenko
2015 ◽
Vol 0
(0)
◽
pp. 41
2004 ◽
Vol 7
(6)
◽
pp. 668-669
◽
L Niculescu
◽
AW Using
◽
PJ Neumann
2007 ◽
Vol 10
(3)
◽
pp. A204
J Grossomanides
◽
C Possidente
2014 ◽
Vol 17
(7)
◽
pp. A508
J. Walczak
◽
A. Bierut
◽
J. Dowgiallo
◽
K. Pacocha
◽
I. Pieniazek
◽
...
2002 ◽
Vol 8
(5)
◽
pp. 343-352
◽
Les Noe
◽
Russell Becker
◽
Todd Williamson
◽
Donny Chen
1997 ◽
Vol 54
(10)
◽
pp. 1185-1190
◽
David W. Hawkins
◽
Paul C. Langley
◽
Kem P. Krueger
2007 ◽
Vol 13
(6 Supp A)
◽
pp. 1-18
Daniel C. Malone
◽
John G. Tierney
2004 ◽
Vol 7
(6)
◽
pp. 675-676
◽
AE Ratcliffe
◽
SM Beard
◽
S Wolowacz